Search Results

Christel Menet "I did my Ph.D. in Manchester UK with Prof Jonathan Clayden in organic chemistry. After 2 years, I joined Galapagos where I spent almost 11 years and became head of medicinal chemistry

Trained as a medicinal chemist at the University of Chieti in Italy, she completed her PhD in computational medicinal chemistry before spending a formative period in Gerhard Klebe's structural biology lab in chemistry to bitter taste receptors 05:44 Trace amine-associated receptors on the edge of neuroscience So the research is more food-oriented and food-chemistry-oriented — this is why we have knowledge about Antonella trained as a medicinal chemist in Italy, followed by a Ph.D. in computational medicinal chemistry

Jacobson received his BA in Liberal Arts from Reed College in 1976 and his Ph.D. in Chemistry from the currently the Senior Investigator and Chief of the Molecular Recognition Section, Laboratory of Bioorganic Chemistry His numerous awards include: 2008 Sato Award; 2009 Medicinal Chemistry Hall of Fame (American Chemical

From 2015 to 2019, he completed his Ph.D. in the Medicinal Chemistry group at VU University Amsterdam Timo De Groof on the web LinkedIn Researchgate Twitter Medical Imaging Group Google Scholar Dr.

She earned her PhD in medicinal chemistry from the University of Bari in 2018, including research training Her work centers on GPCR modulators, synthetic chemistry, and enabling robust biological assays through By combining fluorophore design, ligand chemistry, and pharmacology, his work enables precise visualization David Hodson is the Robert Turner Professor of Diabetic Medicine at the University of Oxford and a leading Leibniz Research Institute for Molecular Pharmacology (FMP) Profile David Hodson Radcliffe Department of Medicine

She began as a medicinal chemist in Italy, but a postdoc opportunity in Santiago de Compostela—and a Pivoting: From Chemistry Company to Discovery Partner Initially focused on tool production, Celtarys “We always start with the problem, then generate the right compound using our chemistry. Together, we’re combining chemistry, biology, and business insight to empower the GPCR research community Her scientific expertise is rooted in organic synthesis and medicinal chemistry, with a particular focus

GPCR x Celtarys Reseach Empowering medicinal biochemists Celtarys empowers medicinal biochemists by providing Maria Majellaro earned her degree in Pharmaceutical Chemistry and Technology from the University of Bari and completed her PhD in Biomolecular Sciences in Pharmacology and Medicine as “Doctor Europeus” in Her work focuses on organic synthesis, medicinal chemistry, and the development of GPCR-targeted tools

psychedelic for depression — and why the real bottleneck in GPCR drug discovery is the biology, not the chemistry discovery against GPCRs actually requires, why most hypotheses still fail at the indication rather than the chemistry Key Insights from the Conversation The bottleneck in GPCR drug discovery is the indication, not the chemistry Roth is direct about this: with sufficient medicinal chemistry resources and modern assays, you can make Six weeks in, structures are turning over and chemistry is iterating.

Arthur Christopoulos of Monash University in Australia, one of the pioneers in the medicinal chemistry

pharmacology - UK April 3 - 6, 2025 | ASPET 2025 - USA NEW April 14 - 17, 2025 | 20th Drug Discovery Chemistry NEW May 1 - 2, 2025 | 5th Ace Drug Discovery Summit 2025 - USA NEW May 12 - 15, 2025 | ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025 - USA May 12 - 15, 2025 | PEGS 2025 - USA May 15 - 17, 2025 | 23rd GPCR Retreat University Structural Biologist - Confo Therapeutics Associate Director/Director, Platform & Hit-ID Chemistry University of Barcelona GPCR Molecular Pharmacologist - Schrödinger Scientist - Biology - Superluminal Medicines

That opened up a new world.” – Alessandro Nicoli That early spark led him to discover the role of medicinal chemistry and, eventually, molecular modeling. For Nicoli, chemistry became more than reactions—it became a bridge to biological insight. Nicoli dove into computational chemistry. “We’re living in a golden era for computational chemistry… the tools are out there.

For Comeo, who entered GPCR research without any background in the field and built her PhD around chemistry A trained medicinal chemist and pharmacist, her research focuses on the design and synthesis of fluorescent SCIENTIFIC THEMES OF THE CONVERSATION Fluorescent ligands as pharmacological tools - how synthetic chemistry "In chemistry, it's like when you finally see the NMR of your structure without anything but your compound About this episode Eleonora Comeo is a doctoral candidate in Medicinal Chemistry and Drug Discovery in

computational and mathematical modelling, structural and chemical biology, molecular and cellular pharmacology, medicinal chemistry, and preclinical models of behaviour and disease. In 2017, he was elected a Fellow of the Australian Academy of Health and Medical Sciences, in 2018 as the potential of certain drugs, like flumazenil, as 'nails' or compounds that could be developed into medicines

Clinical Pharmacology GPCR Jobs Structural Biologist Associate Director/Director, Platform & Hit-ID Chemistry Pharmacologist Scientist - Biology Scientist I Cell Biology - Tectonic Therapeutic Senior Principal Scientist, Medicinal Chemistry PhD fellowship in GPCR mechanosensing GPCR Activation and Signaling Lineage-Specific Class-A

computational and mathematical modelling, structural and chemical biology, molecular and cellular pharmacology, medicinal chemistry, and preclinical models of behaviour and disease. In 2017, he was elected a Fellow of the Australian Academy of Health and Medical Sciences, in 2018 as

computational and mathematical modelling, structural and chemical biology, molecular and cellular pharmacology, medicinal chemistry, and preclinical models of behaviour and disease. In 2017, he was elected a Fellow of the Australian Academy of Health and Medical Sciences, in 2018 as

Structural snapshots of receptor-ligand complexes can validate docking predictions and guide medicinal chemistry. 4. childhood curiosity about toxic plants led to an interest in drug research. 05:00 — Choosing science over medicine Transition from a pre-medical track to pursuing scientific research. 07:00 — Discovering cryo-electron One of my close friends at the time noticed how quickly I pivoted once I realized that medicine wasn’

Dylan Eiger About Dylan Eiger Dylan Eiger is currently an MD/Ph.D. student at Duke University School of Medicine He received his B.S. in Chemistry from Duke University in 2016 where he worked in the lab of Dr. Stephen Craig and studied polymer chemistry and material science. After finishing his MD/Ph.D., Dylan plans to complete his residency training in Internal Medicine and

Human Health, as well as the Dean of The Graduate School of Biomedical Sciences at the Icahn School of Medicine A native of Italy, she received her Bachelor’s and Master’s degrees in Chemistry from the University She pursued a Ph.D. in Computational Chemistry at the Second University of Naples and a postdoctorate Marta Filizola on the web Icahn School of Medicine at Mount Sinai Filizola Lab Wikipedia Twitter Linkedin

Sudarshan Rajagopal obtained his B.S. in Chemistry from The University of Chicago in 1998. He subsequently enrolled in the Medical Scientist Training Program at The University of Chicago. He then joined the Internal Medicine Residency training program at Duke University Medical Center. After completing his training in clinical cardiology, he started as an Assistant Professor of Medicine at Duke University School of Medicine.

After spending two years at the Cleveland Institute of Art, he earned degrees in Biochemistry and Chemistry recruited to the Molecular and Cellular Pharmacology Department at the University of Miami Miller School of Medicine sequence- and structure-based informaticist, computational geometer, virtual screener, and Python, medical Daniel Isom on the web Isom Lab University of Miami Miller School of Medicine LinkedIn X (Twitter) BlueSky

visualization tools changed our understanding of GPCR signaling in metabolic tissues What collaborative chemistry innovation with the need for reproducible, well-controlled functional assays Worked across disciplines where chemistry David Hodson is the Robert Turner Professor of Diabetic Medicine at the University of Oxford , working David Hodson on the Web Radcliffe Department of Medicine Islet Biology Lab University of Birmingham Unlock

He studied Medicine in Milan and Stockholm, and obtained a PhD in Molecular Medicine and a Clinical Specialisation He leads a multidisciplinary research team comprising biologists, chemists, physicists, engineers and has been published in prestigious scientific journals such as Nature, Cell, New England Journal of Medicine and committees, including the ENDO Annual Meeting Steering Committee and the MRC Molecular & Cellular Medicine

John Janetzko "I received my Honors BSc in Chemistry from the University of Toronto in 2011, with a focus on synthetic organic and inorganic chemistry. Following this, I pursued graduate studies in Chemistry at Harvard University. He participated in various academic competitions, including math, physics, and chemistry contests. John's Chemistry Olympiad and GPCR Journey John shared his experience with the Chemistry Olympiad program

Terry Kenakin After obtaining a BSc in chemistry at the University of Alberta Edmonton Canada, Terry received his Ph.D. in Pharmacology from the University of Alberta, Department of Chemistry, Canada. Since 2011, Terry works at the Department of Pharmacology at the University of North Carolina School of Medicine

Molecular Pharmacology Research Unit, as well as Professor in the Department of Biochemistry and Molecular Medicine final edited audio before publishing. 00:00 Introduction 02:23 Scientific origin - the high school chemistry Michel Bouvier Michel Bouvier is a professor of Biochemistry and Molecular Medicine and the CEO of the Council of Canada at the Faculty of Medicine of the Université de Montréal. Pubmed ResearchGate Twitter LinkedIn Universite de Montreal- Department of Biochemistry and Molecular Medicine

Nagarajan Vaidehi, Ph.D., is professor and chair of the Department of Computational and Quantitative Medicine Vaidehi received her Ph.D. in quantum chemistry from the Indian Institute of Technology in India, where

Caron and his family moved to Durham, NC in 1977, following receipt of his BSc in Chemistry from Laval He joined the faculty of Laval University School of Medicine in 1975 and then returned to join Duke’s Caron was an investigator of the Howard Hughes Medical Institute from 1992 to 2004, a member of the American

Ajay Yekkirala is a GPCR pharmacologist, biotech entrepreneur, and co-founder of Superluminal Medicines Why This Matters Translating basic GPCR science into actual medicines is broken. Ajay’s work sits at the intersection of GPCR biology, AI, and translational medicine. Ajay Yekkirala on the web Superluminal Medicines LinkedIn Tune in now to hear how asking “what if?” led Ajay Yekkirala to reshape the future of GPCR-targeted medicine. Unlock the Full Dr.

Caron and his family moved to Durham, NC in 1977, following receipt of his BSc in Chemistry from Laval He joined the faculty of Laval University School of Medicine in 1975 and then returned to join Duke’s Caron was an investigator of the Howard Hughes Medical Institute from 1992 to 2004, a member of the American